darunavir has been researched along with colforsin in 1 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | darunavir (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azoulay, S; Dani, C; Ladoux, A; Mazure, NM; Paré, M; Ravaud, C; Yao, X | 1 |
1 other study(ies) available for darunavir and colforsin
| Article | Year |
|---|---|
Resveratrol and HIV-protease inhibitors control UCP1 expression through opposite effects on p38 MAPK phosphorylation in human adipocytes.
Topics: Adipocytes; Antioxidants; Cell Line; Colforsin; Darunavir; Gene Expression Regulation; HIV Protease Inhibitors; Humans; Organic Chemicals; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Uncoupling Protein 1 | 2020 |